Cargando…
Timing the Emergence of Resistance to Anti-HIV Drugs with Large Genetic Barriers
New antiretroviral drugs that offer large genetic barriers to resistance, such as the recently approved inhibitors of HIV-1 protease, tipranavir and darunavir, present promising weapons to avert the failure of current therapies for HIV infection. Optimal treatment strategies with the new drugs, howe...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643484/ https://www.ncbi.nlm.nih.gov/pubmed/19282958 http://dx.doi.org/10.1371/journal.pcbi.1000305 |